Rituximab Trial And Research



From Invest In ME Research.


Statement Following Preliminary Phase III Rituximab Clinical trial Results from Norway

Following the preliminary results which Professor Olav Mella recently publicly released from the Phase III multi-centre double-blinded placebo-controlled Rituximab Clinical Trial (see statement 21st November 2017) the charity has had discussions with advisors and researchers and has now received further communication from Dr Fluge in Norway.

Invest in ME Research has issued the statement below regarding the planned UK trial.

The Haukeland team will be presenting at the IIMEC13 13th International ME Conference in London on 1st June 2018


To read the rest of this story, click on the link below:


Link to ME story

Leave a Reply

The York ME Community © 2015
Powered by Live Score & Live Score App